Related Experiment Video
Updated: Jul 12, 2025
09:56
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
562
Advances in mRNA-Based Cancer Vaccines
1Institute for Immunology and School of Medicine, Tsinghua University, Medical Research Building, No. 30 Haidian Shuangqing Road, Beijing 100084, China.
Vaccines
|October 28, 2023
Summary
Messenger RNA (mRNA) cancer vaccines are gaining traction, leveraging recent technological advances. This review highlights progress in mRNA cancer vaccine development, clinical trials, and future immunotherapy applications.
Area of Science:
- Oncology
- Immunology
- Biotechnology
Background:
- Cancer remains a leading global cause of mortality, necessitating innovative treatment strategies.
- Cancer vaccines, a form of immunotherapy, have shown preclinical promise but faced clinical translation challenges.
- The success of mRNA technology in the COVID-19 pandemic has revitalized interest in mRNA-based cancer vaccines.
Purpose of the Study:
- To review recent advancements in mRNA-based cancer vaccines over the past five years.
- To summarize key aspects including mechanism of action, neoantigen discovery, adjuvants, and delivery systems.
- To provide an overview of current clinical trials and future directions for mRNA cancer vaccines in immunotherapy.
Main Methods:
- Literature review focusing on scientific publications and clinical trial data from the last five years.
- Synthesis of information on mRNA vaccine technology, cancer immunology, and therapeutic development.
- Analysis of progress in neoantigen identification, adjuvant formulation, and nanoparticle-based delivery systems.
Main Results:
- Significant progress has been made in mRNA cancer vaccine technology, driven by advancements in delivery systems and adjuvant development.
- Current clinical trials are evaluating the safety and efficacy of various mRNA cancer vaccine candidates across different cancer types.
- The review consolidates current understanding of mRNA vaccine mechanisms and their potential in personalized cancer treatment.
Conclusions:
- mRNA cancer vaccines represent a promising frontier in cancer immunotherapy, building on recent technological breakthroughs.
- Continued research into neoantigen discovery, optimized delivery, and combination therapies will be crucial for clinical success.
- This review provides valuable insights for researchers advancing mRNA-based strategies for cancer treatment.
Related Concept Videos
01:30Cancer Vaccines
383
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
383
01:29Microorganisms in Medicine and Therapeutics
35
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
35
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:27Tumor Immunotherapy
538
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
538
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K